These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30862420)

  • 1. Defining the Tumor Microenvironment of Penile Cancer by Means of the Cancer Immunogram.
    de Vries HM; Ottenhof SR; Horenblas S; van der Heijden MS; Jordanova ES
    Eur Urol Focus; 2019 Sep; 5(5):718-721. PubMed ID: 30862420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune-checkpoint status in penile squamous cell carcinoma: a North American cohort.
    Cocks M; Taheri D; Ball MW; Bezerra SM; Del Carmen Rodriguez M; Ricardo BFP; Bivalacqua TJ; Sharma RB; Meeker A; Chaux A; Burnett AL; Netto GJ
    Hum Pathol; 2017 Jan; 59():55-61. PubMed ID: 27663086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prognostic Value of Immune Factors in the Tumor Microenvironment of Penile Squamous Cell Carcinoma.
    Ottenhof SR; Djajadiningrat RS; Thygesen HH; Jakobs PJ; Jóźwiak K; Heeren AM; de Jong J; Sanders J; Horenblas S; Jordanova ES
    Front Immunol; 2018; 9():1253. PubMed ID: 29942303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent PD-L1 expression in primary and metastatic penile squamous cell carcinoma: potential opportunities for immunotherapeutic approaches.
    Udager AM; Liu TY; Skala SL; Magers MJ; McDaniel AS; Spratt DE; Feng FY; Siddiqui J; Cao X; Fields KL; Morgan TM; Palapattu GS; Weizer AZ; Chinnaiyan AM; Alva A; Montgomery JS; Tomlins SA; Jiang H; Mehra R
    Ann Oncol; 2016 Sep; 27(9):1706-12. PubMed ID: 27217541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune landscape and immunotherapy for penile cancer.
    Tang Y; Hu X; Wu K; Li X
    Front Immunol; 2022; 13():1055235. PubMed ID: 36524123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for Efficacy of Treatment With the Anti-PD-1 Mab Nivolumab in Radiation and Multichemorefractory Advanced Penile Squamous Cell Carcinoma.
    Trafalis DT; Alifieris CE; Kalantzis A; Verigos KE; Vergadis C; Sauvage S
    J Immunother; 2018; 41(6):300-305. PubMed ID: 29642086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Systemic treatment of locally advanced or metastatic penile cancer].
    Gassian N; Frontczak A; El Kaddissi A; Calcagno F; Almotlak H; Barkatz J; Mouillet G; Maurina T; Stein U; Nguyen Tan Hon T; Murez T; Thiery-Vuillemin A
    Bull Cancer; 2020 Jun; 107(5S):S17-S23. PubMed ID: 32620202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity and tolerability of maintenance avelumab immunotherapy after first line polychemotherapy including platinum in patients with locally advanced or metastatic squamous cell penile carcinoma: PULSE.
    Gassian N; Frontczak A; Mouillet G; Vernerey D; Manseur O; Goujon M; Meurisse A; Berthod D; Robert E; Calcagno F; Thiery-Vuillemin A
    Bull Cancer; 2020 Jun; 107(5S):eS16-eS21. PubMed ID: 32620211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penile cancer: potential target for immunotherapy?
    Vanthoor J; Vos G; Albersen M
    World J Urol; 2021 May; 39(5):1405-1411. PubMed ID: 33145666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
    Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
    J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating advanced penile cancer: where do we stand in 2019?
    Aydin AM; Cheriyan S; Spiess PE
    Curr Opin Support Palliat Care; 2019 Sep; 13(3):249-254. PubMed ID: 31082941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.
    Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M
    J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equine Penile Squamous Cell Carcinomas as a Model for Human Disease: A Preliminary Investigation on Tumor Immune Microenvironment.
    Porcellato I; Mecocci S; Mechelli L; Cappelli K; Brachelente C; Pepe M; Orlandi M; Gialletti R; Passeri B; Ferrari A; Modesto P; Ghelardi A; Razzuoli E
    Cells; 2020 Oct; 9(11):. PubMed ID: 33121116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Immune Microenvironment in Penile Cancer and Rationale for Immunotherapy.
    Ahmed ME; Falasiri S; Hajiran A; Chahoud J; Spiess PE
    J Clin Med; 2020 Oct; 9(10):. PubMed ID: 33080912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
    Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
    JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PD-L1 Expression in Men with Penile Cancer and its Association with Clinical Outcomes.
    Davidsson S; Carlsson J; Giunchi F; Harlow A; Kirrander P; Rider J; Fiorentino M; Andrén O
    Eur Urol Oncol; 2019 Mar; 2(2):214-221. PubMed ID: 31017099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future directions in advanced penile cancer - mechanisms of carcinogenesis and a search for targeted therapy.
    Teh J; O'Connor E; O'Brien J; Lim WM; Taylor M; Heriot A; Ramsay R; Lawrentschuk N
    Future Oncol; 2020 Oct; 16(29):2357-2369. PubMed ID: 32713198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced penile carcinoma.
    Culkin DJ; Beer TM
    J Urol; 2003 Aug; 170(2 Pt 1):359-65. PubMed ID: 12853775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of PD-L1 expression and CD8+ T cells infiltration in patients with EGFR-mutated and ALK-rearranged lung cancer.
    Liu SY; Dong ZY; Wu SP; Xie Z; Yan LX; Li YF; Yan HH; Su J; Yang JJ; Zhou Q; Zhong WZ; Tu HY; Yang XN; Zhang XC; Wu YL
    Lung Cancer; 2018 Nov; 125():86-92. PubMed ID: 30429043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune-based therapies in penile cancer.
    Joshi VB; Spiess PE; Necchi A; Pettaway CA; Chahoud J
    Nat Rev Urol; 2022 Aug; 19(8):457-474. PubMed ID: 35851333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.